Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Astellas Pharma Inc.
YPHACurrent price
10.9 EUR
0 EUR (0.00%)
Last closed
1 750 JPY
Company
www.astellas.com
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
Frankfurt Exchange
Capitalization
3 187 100 265 673 JPY
Yield for 12 month
-18.73 %
1Y
3Y
5Y
10Y
15Y
YPHA
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan. Address: 2-5-1, Nihonbashi-Honcho, Tokyo, Japan, 103-8411
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
278 041.63 JPYP/E ratio
148.8825Dividend Yield
4.23 %Current Year
+1 587 748 790 238 JPY
Last Year
+1 503 540 300 094 JPY
Current Quarter
+468 426 248 423 JPY
Last Quarter
+410 485 326 073 JPY
Current Year
+1 200 329 143 156 JPY
Last Year
+1 218 050 419 961 JPY
Current Quarter
+343 550 600 863 JPY
Last Quarter
+305 660 592 039 JPY
Key Figures YPHA
1 year
3 years
5 years
10 years
EBITDA
277 208 922 103 JPY
Operating Margin TTM
PE Ratio
148.8825
Return On Assets TTM
1.82 %
PEG Ratio
–
Return On Equity TTM
1.32 %
Wall Street Target Price
278 041.63 JPY
Revenue TTM
1 684 908 345 720 JPY
Book Value
926.94 JPY
Revenue Per Share TTM
Dividend Share
69.3 JPY
Quarterly Revenue Growth YOY
26.2 %
Dividend Yield
4.23 %
Gross Profit TTM
1 032 796 295 946 JPY
Earnings per share
11.96 JPY
Diluted Eps TTM
11.96 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
13.7 %
Profit Margin
1.26 %
Dividend Analytics YPHA
Champion
- 10+ consecutive years of dividend increases
Dividend growth over 5 years
76 %Continuous growth
10 yearsPayout Ratio 5 years average
195 %Dividend History YPHA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
74
Ex Dividend Date
27.09.2024
Forward Annual Dividend Yield
4.23 %
Last Split Factor
5:1
Payout Ratio
5.81 %
Last Split Date
27.03.2014
Dividend Date
–
Stock Valuation YPHA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
148.8825
Forward PE
12.3457
Enterprise Value Revenue
2.167
Price Sales TTM
1.8916
Enterprise Value EBITDA
16.2274
Price Book MRQ
1.9626
Financials YPHA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators YPHA
For 52 weeks
1 411.84 JPY
2 137.76 JPY
50 Day MA
1 612.87 JPY
Shares Short Prior Month
–
200 Day MA
1 628.44 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart